Skip to main content

Table 3 Waist size: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

Waist circumference (mean cm)

Waist change (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

110.50 ± 7.28

105.38 ± 10.64a

-4.64‡

Formula A (↓dose)

104.00 ± 8.63

99.40 ± 11.73a

-4.42†

Placebo

105.60 ± 7.91

105.00 ± 15.77

-0.57

  1. ap < 0.05; bp < 0.001 compared with Placebo
  2. *p < 0.05; **p < 0.001 compared with Formula A
  3. †p < 0.05; ‡p < 0.001 compared with Initial; intragroup analysis
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X